Fact CheckerSign in

NCT05501119Completed

SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers

Palliative Care Telehealth Delivered Program of SUPPORT-D Intervention for Persons With Alzheimer's Disease and Caregivers Phase 2

Source: ClinicalTrials.gov · Last updated 8 Apr 2025

Brief summary (registry, in English)

The purpose of this research is pilot test a nurse led intervention previously used in patients with pulmonary fibrosis and their caregivers in a new population (persons living with Mild Cognitive Impairment or Alzheimer's disease and their caregivers. The researchers hypothesize improving advanced care planning in this population will result in enhanced quality of life over illness trajectory and improve safety for community dwelling PWD/CG dyads. Findings from this study will inform additional necessary adaptations required prior to conducting larger scale powered randomized control trial.

Status (registry)
Completed
Study type
Interventional
Enrollment
58 (actual)
First submitted
9 Aug 2022
Start date
27 Jan 2023
Primary completion date
1 Apr 2024
Lead sponsor
Medical University of South Carolina
NCT number
NCT05501119

What you commit to

  • Study type: Interventional
  • Participants enrolled: 58
  • From 27 Jan 2023 to the primary completion date, 1 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Inability or unwillingness to provide informed consent

Who the study is looking for

  • The participants in this study include persons with Alzheimer's disease (PWD) and their caregivers (CG.
  • Persons with Alzheimer's Disease (investigators anticipate cognitive impairment within this group)
  • 18 years old or older
  • Diagnosis of Alzheimer's Disease or suspected Alzheimer's disease (FAST score \< 4)
  • Able to read and speak English (intervention in English)
    • Caregivers (CG)
  • \> 18 years old
  • Non-paid (eliminates professional caregivers)
  • Provides care to someone living with Alzheimer's Disease or suspected Alzheimer's disease (self-report)
  • Able to read and speak English (written materials in English)
  • No diagnosis of cognitive impairment

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of South Carolina
Coordinator of this site? Confirm its status
CharlestonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.